Researchers at University Hospitals and Case Western Reserve University have discovered an enzyme that appears to play a key ...

Childhood obesity reflects our modern environment of ultra-processed foods, digital devices and psychological stressors. To ...

While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof De ...

GLP-1 receptor agonists have captured global attention for their ability to drive weight loss and improve metabolic health.

The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...

India, known for its generic drug industry, is rapidly transforming into a major hub for the global weight management ...

Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Novo Nordisk and Eli Lilly are reducing prices for their widely used obesity medications, Wegovy and Mounjaro, in China, a ...

Anecdotal stories suggesting that weight-loss drugs can help people shake long-standing addictions have been spreading fast ...